Our findings detected strong and weak levels of nuclear DLC1 expression in the majority of primary and metastatic melanomas, whereas previous studies revealed a marked reduction in the percentage of samples with nuclear DLC1 expression in metastatic melanomas compared with primary melanomas [17]. Here, DLC1 is linked to melanoma.